Cleared Traditional

K910822 - BARD PERIPHERAL BALLOON DILATATION CATHETER

K910822 is an FDA 510(k) clearance for BARD PERIPHERAL BALLOON DILATATION CATHETER, manufactured by C.R. Bard, Inc.. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 184-day FDA review.

K910822 · C.R. Bard, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1991
Decision
184d
Days
Class 2
Risk

K910822 is an FDA 510(k) clearance for the BARD PERIPHERAL BALLOON DILATATION CATHETER. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Murray Hill, US). The FDA issued a Cleared decision on August 29, 1991 after a review of 184 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all C.R. Bard, Inc. devices

FDA 510(k) Submission Details - K910822

510(k) Number K910822 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 26, 1991
Decision Date August 29, 1991
Days to Decision 184 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d slower than avg
Panel avg: 125d · This submission: 184d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 345
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K910822.
TEGWIRE (TM)
K913391 · Boston Scientific Corp · Nov 1991
SUB-4(TM), PERIPHERAL DILATATION CATHETER
K913689 · Boston Scientific Corp · Oct 1991
SCHNEIDER MATCH-35(TM) PERCU TRANS ANGIOPLAS CATH
K913297 · Schneider Intl., Ltd. · Oct 1991
SCHNEIDER MONORAIL 421 PERCU TRANS ANGIO PTA CATH
K912317 · Schneider Intl., Ltd. · Aug 1991
OPTI-PLAST 5F PTA CATHETERS
K913112 · Vas-Cath, Inc. · Aug 1991
OPTI-PLAST 5F PTA CATHETERS, MODIFICATION
K912984 · Vas-Cath, Inc. · Aug 1991